These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12096009)

  • 1. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement.
    Lovering AM; Zhang J; Bannister GC; Lankester BJ; Brown JH; Narendra G; MacGowan AP
    J Antimicrob Chemother; 2002 Jul; 50(1):73-7. PubMed ID: 12096009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the penetration of cefuroxime and cephamandole into bone, fat and haematoma fluid in patients undergoing total hip replacement.
    Lovering AM; Perez J; Bowker KE; Reeves DS; MacGowan AP; Bannister G
    J Antimicrob Chemother; 1997 Jul; 40(1):99-104. PubMed ID: 9249210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone.
    Lovering AM; Walsh TR; Bannister GC; MacGowan AP
    J Antimicrob Chemother; 2001 Apr; 47(4):483-6. PubMed ID: 11266427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid penetration into osteo-articular tissues.
    Rana B; Butcher I; Grigoris P; Murnaghan C; Seaton RA; Tobin CM
    J Antimicrob Chemother; 2002 Nov; 50(5):747-50. PubMed ID: 12407135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of linezolid into sternal bone of patients undergoing cardiopulmonary bypass surgery.
    Metallidis S; Nikolaidis J; Lazaraki G; Koumentaki E; Gogou V; Topsis D; Nikolaidis P; Charokopos N; Theodoridis G
    Int J Antimicrob Agents; 2007 Jun; 29(6):742-4. PubMed ID: 17374477
    [No Abstract]   [Full Text] [Related]  

  • 6. Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci.
    Kutscha-Lissberg F; Hebler U; Muhr G; Köller M
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3964-6. PubMed ID: 14638510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of linezolid via continuous venovenous hemodiafiltration.
    Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D
    Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA.
    Swoboda S; Helbig L; Kommerell M; Simank HG; Kees F; Geiss HK; Hoppe-Tichy T; Schröder K
    Pharmazie; 2009 Jun; 64(6):407-9. PubMed ID: 19618680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid pharmacokinetics in an obese patient.
    Mersfelder TL; Smith CL
    Am J Health Syst Pharm; 2005 Mar; 62(5):464, 467. PubMed ID: 15745906
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.
    Gee T; Ellis R; Marshall G; Andrews J; Ashby J; Wise R
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1843-6. PubMed ID: 11353635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: a case report.
    Pea F; Cadeo B; Cojutti PG; Pecori D; Bassetti M
    Ther Drug Monit; 2014 Oct; 36(5):687-9. PubMed ID: 24646731
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.
    Stolle LB; Plock N; Joukhadar C; Arpi M; Emmertsen KJ; Buerger C; Riegels-Nielsen P; Kloft C
    Scand J Infect Dis; 2008; 40(1):24-9. PubMed ID: 18097982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.
    Majcher-Peszynska J; Haase G; Sass M; Mundkowski R; Pietsch A; Klammt S; Schareck W; Drewelow B
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1093-100. PubMed ID: 18654767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.
    Eslam RB; Burian A; Vila G; Sauermann R; Hammer A; Frenzel D; Minichmayr IK; Kloft C; Matzneller P; Oesterreicher Z; Zeitlinger M
    J Clin Pharmacol; 2014 Sep; 54(9):1058-62. PubMed ID: 24677034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of bone and fat concentrations following systemic cefamandole and regional cefuroxime administration in patients undergoing knee arthroplasty.
    Hoddinott C; Lovering AM; Fernando HC; Dixon JH; Reeves DS
    J Antimicrob Chemother; 1990 Dec; 26(6):823-9. PubMed ID: 2081721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid penetration into cerebrospinal fluid and brain tissue.
    Tsona A; Metallidis S; Foroglou N; Selviaridis P; Chrysanthidis T; Lazaraki G; Papaioannou M; Nikolaidis J; Nikolaidis P
    J Chemother; 2010 Feb; 22(1):17-9. PubMed ID: 20227987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
    Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
    Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.
    Dehghanyar P; Bürger C; Zeitlinger M; Islinger F; Kovar F; Müller M; Kloft C; Joukhadar C
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2367-71. PubMed ID: 15917535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid pharmacokinetics in patients with acute renal failure undergoing continuous venovenous hemodiafiltration.
    Carcelero E; Soy D; Guerrero L; Poch E; Fernandez J; Castro P; Ribas J
    J Clin Pharmacol; 2012 Sep; 52(9):1430-5. PubMed ID: 21960670
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections.
    Villani P; Regazzi MB; Marubbi F; Viale P; Pagani L; Cristini F; Cadeo B; Carosi G; Bergomi R
    Antimicrob Agents Chemother; 2002 Mar; 46(3):936-7. PubMed ID: 11850294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.